nodes	percent_of_prediction	percent_of_DWPC	metapath
Mitoxantrone—TOP2A—polycystic ovary syndrome	0.452	1	CbGaD
Mitoxantrone—SLC47A1—Metformin—polycystic ovary syndrome	0.365	1	CbGbCtD
Mitoxantrone—Tonsillitis—Metformin—polycystic ovary syndrome	0.00414	0.167	CcSEcCtD
Mitoxantrone—SLC47A2—vagina—polycystic ovary syndrome	0.00244	0.0366	CbGeAlD
Mitoxantrone—PIM1—adrenal cortex—polycystic ovary syndrome	0.00238	0.0357	CbGeAlD
Mitoxantrone—CYP2E1—urine—polycystic ovary syndrome	0.00228	0.0341	CbGeAlD
Mitoxantrone—BTK—pituitary gland—polycystic ovary syndrome	0.00222	0.0333	CbGeAlD
Mitoxantrone—BTK—adipose tissue—polycystic ovary syndrome	0.00221	0.0332	CbGeAlD
Mitoxantrone—PIM1—endometrium—polycystic ovary syndrome	0.00213	0.0319	CbGeAlD
Mitoxantrone—BTK—adrenal gland—polycystic ovary syndrome	0.00199	0.0298	CbGeAlD
Mitoxantrone—PIM1—uterus—polycystic ovary syndrome	0.00196	0.0294	CbGeAlD
Mitoxantrone—PIM1—pituitary gland—polycystic ovary syndrome	0.00193	0.0289	CbGeAlD
Mitoxantrone—PIM1—adipose tissue—polycystic ovary syndrome	0.00192	0.0287	CbGeAlD
Mitoxantrone—BTK—female gonad—polycystic ovary syndrome	0.00185	0.0278	CbGeAlD
Mitoxantrone—BTK—vagina—polycystic ovary syndrome	0.00184	0.0276	CbGeAlD
Mitoxantrone—CYP3A4—urine—polycystic ovary syndrome	0.00183	0.0275	CbGeAlD
Mitoxantrone—PIM1—adrenal gland—polycystic ovary syndrome	0.00172	0.0258	CbGeAlD
Mitoxantrone—PIM1—female gonad—polycystic ovary syndrome	0.0016	0.024	CbGeAlD
Mitoxantrone—PIM1—vagina—polycystic ovary syndrome	0.00159	0.0239	CbGeAlD
Mitoxantrone—PIM1—endocrine gland—polycystic ovary syndrome	0.00149	0.0224	CbGeAlD
Mitoxantrone—Fungal infection—Metformin—polycystic ovary syndrome	0.00135	0.0547	CcSEcCtD
Mitoxantrone—SLC47A1—adrenal cortex—polycystic ovary syndrome	0.00128	0.0191	CbGeAlD
Mitoxantrone—TOP2A—endometrium—polycystic ovary syndrome	0.00125	0.0187	CbGeAlD
Mitoxantrone—Contusion—Metformin—polycystic ovary syndrome	0.0012	0.0484	CcSEcCtD
Mitoxantrone—TOP2A—uterus—polycystic ovary syndrome	0.00115	0.0172	CbGeAlD
Mitoxantrone—SLC47A1—endometrium—polycystic ovary syndrome	0.00114	0.0171	CbGeAlD
Mitoxantrone—TOP2A—adipose tissue—polycystic ovary syndrome	0.00113	0.0169	CbGeAlD
Mitoxantrone—SLC47A1—uterus—polycystic ovary syndrome	0.00105	0.0157	CbGeAlD
Mitoxantrone—SLC47A1—pituitary gland—polycystic ovary syndrome	0.00103	0.0155	CbGeAlD
Mitoxantrone—SLC47A1—adipose tissue—polycystic ovary syndrome	0.00103	0.0154	CbGeAlD
Mitoxantrone—TOP2A—adrenal gland—polycystic ovary syndrome	0.00101	0.0151	CbGeAlD
Mitoxantrone—TOP2A—female gonad—polycystic ovary syndrome	0.000941	0.0141	CbGeAlD
Mitoxantrone—TOP2A—vagina—polycystic ovary syndrome	0.000936	0.014	CbGeAlD
Mitoxantrone—SLC47A1—adrenal gland—polycystic ovary syndrome	0.000922	0.0138	CbGeAlD
Mitoxantrone—SLC47A1—female gonad—polycystic ovary syndrome	0.00086	0.0129	CbGeAlD
Mitoxantrone—SLC47A1—vagina—polycystic ovary syndrome	0.000854	0.0128	CbGeAlD
Mitoxantrone—ABCC1—adrenal cortex—polycystic ovary syndrome	0.000842	0.0126	CbGeAlD
Mitoxantrone—SLC47A1—endocrine gland—polycystic ovary syndrome	0.000799	0.012	CbGeAlD
Mitoxantrone—CYP1B1—uterus—polycystic ovary syndrome	0.00077	0.0115	CbGeAlD
Mitoxantrone—CYP1B1—pituitary gland—polycystic ovary syndrome	0.000756	0.0113	CbGeAlD
Mitoxantrone—CYP1B1—adipose tissue—polycystic ovary syndrome	0.000753	0.0113	CbGeAlD
Mitoxantrone—ABCC1—endometrium—polycystic ovary syndrome	0.000752	0.0113	CbGeAlD
Mitoxantrone—Dehydration—Metformin—polycystic ovary syndrome	0.000706	0.0285	CcSEcCtD
Mitoxantrone—ABCG2—adrenal cortex—polycystic ovary syndrome	0.000697	0.0104	CbGeAlD
Mitoxantrone—Abdominal pain upper—Metformin—polycystic ovary syndrome	0.000693	0.028	CcSEcCtD
Mitoxantrone—ABCC1—uterus—polycystic ovary syndrome	0.000693	0.0104	CbGeAlD
Mitoxantrone—ABCC1—pituitary gland—polycystic ovary syndrome	0.00068	0.0102	CbGeAlD
Mitoxantrone—ABCC1—adipose tissue—polycystic ovary syndrome	0.000678	0.0102	CbGeAlD
Mitoxantrone—CYP1B1—adrenal gland—polycystic ovary syndrome	0.000676	0.0101	CbGeAlD
Mitoxantrone—Sweating increased—Metformin—polycystic ovary syndrome	0.000639	0.0258	CcSEcCtD
Mitoxantrone—CYP1B1—female gonad—polycystic ovary syndrome	0.00063	0.00944	CbGeAlD
Mitoxantrone—ABCG2—endometrium—polycystic ovary syndrome	0.000622	0.00933	CbGeAlD
Mitoxantrone—Neutropenia—Metformin—polycystic ovary syndrome	0.000613	0.0248	CcSEcCtD
Mitoxantrone—Upper respiratory tract infection—Metformin—polycystic ovary syndrome	0.00061	0.0246	CcSEcCtD
Mitoxantrone—ABCC1—adrenal gland—polycystic ovary syndrome	0.000608	0.00911	CbGeAlD
Mitoxantrone—CYP1B1—endocrine gland—polycystic ovary syndrome	0.000586	0.00878	CbGeAlD
Mitoxantrone—Drowsiness—Metformin—polycystic ovary syndrome	0.000585	0.0236	CcSEcCtD
Mitoxantrone—ABCG2—uterus—polycystic ovary syndrome	0.000574	0.0086	CbGeAlD
Mitoxantrone—ABCC1—female gonad—polycystic ovary syndrome	0.000567	0.00849	CbGeAlD
Mitoxantrone—ABCC1—vagina—polycystic ovary syndrome	0.000563	0.00844	CbGeAlD
Mitoxantrone—ABCG2—pituitary gland—polycystic ovary syndrome	0.000563	0.00844	CbGeAlD
Mitoxantrone—ABCG2—adipose tissue—polycystic ovary syndrome	0.000561	0.00841	CbGeAlD
Mitoxantrone—Bradycardia—Metformin—polycystic ovary syndrome	0.000535	0.0216	CcSEcCtD
Mitoxantrone—Rhinitis—Metformin—polycystic ovary syndrome	0.000526	0.0213	CcSEcCtD
Mitoxantrone—Hepatitis—Metformin—polycystic ovary syndrome	0.000525	0.0212	CcSEcCtD
Mitoxantrone—ABCG2—adrenal gland—polycystic ovary syndrome	0.000503	0.00754	CbGeAlD
Mitoxantrone—Chills—Metformin—polycystic ovary syndrome	0.000471	0.019	CcSEcCtD
Mitoxantrone—ABCG2—female gonad—polycystic ovary syndrome	0.000469	0.00703	CbGeAlD
Mitoxantrone—ABCG2—vagina—polycystic ovary syndrome	0.000466	0.00699	CbGeAlD
Mitoxantrone—Erythema—Metformin—polycystic ovary syndrome	0.000457	0.0185	CcSEcCtD
Mitoxantrone—Dysgeusia—Metformin—polycystic ovary syndrome	0.000448	0.0181	CcSEcCtD
Mitoxantrone—CYP2E1—adrenal gland—polycystic ovary syndrome	0.000436	0.00653	CbGeAlD
Mitoxantrone—Vision blurred—Metformin—polycystic ovary syndrome	0.000431	0.0174	CcSEcCtD
Mitoxantrone—Ill-defined disorder—Metformin—polycystic ovary syndrome	0.000424	0.0171	CcSEcCtD
Mitoxantrone—ABCB1—embryo—polycystic ovary syndrome	0.000419	0.00629	CbGeAlD
Mitoxantrone—Malaise—Metformin—polycystic ovary syndrome	0.000412	0.0167	CcSEcCtD
Mitoxantrone—Hypertension—Metformin—polycystic ovary syndrome	0.000395	0.0159	CcSEcCtD
Mitoxantrone—Myalgia—Metformin—polycystic ovary syndrome	0.000389	0.0157	CcSEcCtD
Mitoxantrone—Chest pain—Metformin—polycystic ovary syndrome	0.000389	0.0157	CcSEcCtD
Mitoxantrone—Discomfort—Metformin—polycystic ovary syndrome	0.000384	0.0155	CcSEcCtD
Mitoxantrone—CYP2E1—endocrine gland—polycystic ovary syndrome	0.000378	0.00566	CbGeAlD
Mitoxantrone—Oedema—Metformin—polycystic ovary syndrome	0.000373	0.0151	CcSEcCtD
Mitoxantrone—Infection—Metformin—polycystic ovary syndrome	0.000371	0.015	CcSEcCtD
Mitoxantrone—Shock—Metformin—polycystic ovary syndrome	0.000367	0.0148	CcSEcCtD
Mitoxantrone—Thrombocytopenia—Metformin—polycystic ovary syndrome	0.000365	0.0148	CcSEcCtD
Mitoxantrone—Skin disorder—Metformin—polycystic ovary syndrome	0.000362	0.0146	CcSEcCtD
Mitoxantrone—Hyperhidrosis—Metformin—polycystic ovary syndrome	0.000361	0.0146	CcSEcCtD
Mitoxantrone—Anorexia—Metformin—polycystic ovary syndrome	0.000356	0.0144	CcSEcCtD
Mitoxantrone—Hypotension—Metformin—polycystic ovary syndrome	0.000349	0.0141	CcSEcCtD
Mitoxantrone—ABCB1—adrenal cortex—polycystic ovary syndrome	0.000344	0.00515	CbGeAlD
Mitoxantrone—Musculoskeletal discomfort—Metformin—polycystic ovary syndrome	0.00034	0.0137	CcSEcCtD
Mitoxantrone—Paraesthesia—Metformin—polycystic ovary syndrome	0.000335	0.0135	CcSEcCtD
Mitoxantrone—Dyspnoea—Metformin—polycystic ovary syndrome	0.000333	0.0134	CcSEcCtD
Mitoxantrone—Somnolence—Metformin—polycystic ovary syndrome	0.000332	0.0134	CcSEcCtD
Mitoxantrone—Dyspepsia—Metformin—polycystic ovary syndrome	0.000328	0.0133	CcSEcCtD
Mitoxantrone—Decreased appetite—Metformin—polycystic ovary syndrome	0.000324	0.0131	CcSEcCtD
Mitoxantrone—Fatigue—Metformin—polycystic ovary syndrome	0.000322	0.013	CcSEcCtD
Mitoxantrone—Constipation—Metformin—polycystic ovary syndrome	0.000319	0.0129	CcSEcCtD
Mitoxantrone—Feeling abnormal—Metformin—polycystic ovary syndrome	0.000307	0.0124	CcSEcCtD
Mitoxantrone—ABCB1—endometrium—polycystic ovary syndrome	0.000307	0.0046	CbGeAlD
Mitoxantrone—Gastrointestinal pain—Metformin—polycystic ovary syndrome	0.000305	0.0123	CcSEcCtD
Mitoxantrone—CYP3A4—endocrine gland—polycystic ovary syndrome	0.000304	0.00456	CbGeAlD
Mitoxantrone—Urticaria—Metformin—polycystic ovary syndrome	0.000296	0.012	CcSEcCtD
Mitoxantrone—Abdominal pain—Metformin—polycystic ovary syndrome	0.000295	0.0119	CcSEcCtD
Mitoxantrone—ABCB1—uterus—polycystic ovary syndrome	0.000283	0.00424	CbGeAlD
Mitoxantrone—ABCB1—pituitary gland—polycystic ovary syndrome	0.000278	0.00416	CbGeAlD
Mitoxantrone—ABCB1—adipose tissue—polycystic ovary syndrome	0.000277	0.00415	CbGeAlD
Mitoxantrone—Asthenia—Metformin—polycystic ovary syndrome	0.000268	0.0108	CcSEcCtD
Mitoxantrone—Diarrhoea—Metformin—polycystic ovary syndrome	0.000255	0.0103	CcSEcCtD
Mitoxantrone—ABCB1—adrenal gland—polycystic ovary syndrome	0.000248	0.00372	CbGeAlD
Mitoxantrone—Vomiting—Metformin—polycystic ovary syndrome	0.000237	0.00958	CcSEcCtD
Mitoxantrone—Rash—Metformin—polycystic ovary syndrome	0.000235	0.0095	CcSEcCtD
Mitoxantrone—Dermatitis—Metformin—polycystic ovary syndrome	0.000235	0.00949	CcSEcCtD
Mitoxantrone—Headache—Metformin—polycystic ovary syndrome	0.000234	0.00944	CcSEcCtD
Mitoxantrone—ABCB1—female gonad—polycystic ovary syndrome	0.000231	0.00347	CbGeAlD
Mitoxantrone—ABCB1—vagina—polycystic ovary syndrome	0.00023	0.00345	CbGeAlD
Mitoxantrone—Nausea—Metformin—polycystic ovary syndrome	0.000222	0.00895	CcSEcCtD
Mitoxantrone—ABCB1—endocrine gland—polycystic ovary syndrome	0.000215	0.00322	CbGeAlD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	3.8e-05	0.000416	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	3.74e-05	0.00041	CbGpPWpGaD
Mitoxantrone—BTK—Adaptive Immune System—AKT2—polycystic ovary syndrome	3.73e-05	0.000409	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.64e-05	0.000399	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKR1C2—polycystic ovary syndrome	3.59e-05	0.000394	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TEAD2—polycystic ovary syndrome	3.59e-05	0.000394	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	3.58e-05	0.000393	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NMNAT3—polycystic ovary syndrome	3.57e-05	0.000391	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	3.54e-05	0.000388	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	3.53e-05	0.000387	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RPL37A—polycystic ovary syndrome	3.47e-05	0.000381	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PNPLA2—polycystic ovary syndrome	3.42e-05	0.000375	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—BCL2—polycystic ovary syndrome	3.39e-05	0.000372	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—AR—polycystic ovary syndrome	3.39e-05	0.000372	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	3.38e-05	0.000371	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL18—polycystic ovary syndrome	3.34e-05	0.000366	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PNPLA2—polycystic ovary syndrome	3.31e-05	0.000363	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—HMMR—polycystic ovary syndrome	3.29e-05	0.000361	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—NRG1—polycystic ovary syndrome	3.27e-05	0.000358	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LPCAT2—polycystic ovary syndrome	3.26e-05	0.000358	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SUOX—polycystic ovary syndrome	3.26e-05	0.000358	CbGpPWpGaD
Mitoxantrone—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	3.26e-05	0.000357	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SRD5A1—polycystic ovary syndrome	3.24e-05	0.000356	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	3.2e-05	0.000351	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	3.17e-05	0.000348	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SRD5A1—polycystic ovary syndrome	3.14e-05	0.000344	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	3.13e-05	0.000343	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—STAR—polycystic ovary syndrome	3.09e-05	0.000339	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	3.09e-05	0.000339	CbGpPWpGaD
Mitoxantrone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—polycystic ovary syndrome	3.08e-05	0.000337	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	3.06e-05	0.000335	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—ISYNA1—polycystic ovary syndrome	3.03e-05	0.000333	CbGpPWpGaD
Mitoxantrone—CYP2E1—Biological oxidations—POMC—polycystic ovary syndrome	3.02e-05	0.000331	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PNPLA2—polycystic ovary syndrome	3.01e-05	0.00033	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—STAR—polycystic ovary syndrome	2.99e-05	0.000328	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	2.98e-05	0.000326	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	2.96e-05	0.000324	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	2.95e-05	0.000324	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	2.95e-05	0.000323	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	2.91e-05	0.000319	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BAX—polycystic ovary syndrome	2.89e-05	0.000316	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SRD5A1—polycystic ovary syndrome	2.85e-05	0.000313	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IRS2—polycystic ovary syndrome	2.8e-05	0.000307	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—CRP—polycystic ovary syndrome	2.8e-05	0.000307	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HMMR—polycystic ovary syndrome	2.76e-05	0.000302	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—STAR—polycystic ovary syndrome	2.72e-05	0.000298	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	2.72e-05	0.000298	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKR1C1—polycystic ovary syndrome	2.71e-05	0.000297	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NMNAT3—polycystic ovary syndrome	2.69e-05	0.000294	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HMMR—polycystic ovary syndrome	2.67e-05	0.000292	CbGpPWpGaD
Mitoxantrone—ABCB1—Allograft Rejection—VEGFA—polycystic ovary syndrome	2.67e-05	0.000292	CbGpPWpGaD
Mitoxantrone—TOP2A—Circadian rythm related genes—IL6—polycystic ovary syndrome	2.65e-05	0.000291	CbGpPWpGaD
Mitoxantrone—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	2.64e-05	0.00029	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HSD3B1—polycystic ovary syndrome	2.63e-05	0.000288	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.6e-05	0.000285	CbGpPWpGaD
Mitoxantrone—ABCC1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.6e-05	0.000285	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKR1C2—polycystic ovary syndrome	2.58e-05	0.000283	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TEAD2—polycystic ovary syndrome	2.58e-05	0.000283	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HSD3B1—polycystic ovary syndrome	2.54e-05	0.000279	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—FGF18—polycystic ovary syndrome	2.52e-05	0.000276	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	2.51e-05	0.000276	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—RBP4—polycystic ovary syndrome	2.5e-05	0.000274	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.46e-05	0.00027	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LPCAT2—polycystic ovary syndrome	2.46e-05	0.000269	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SUOX—polycystic ovary syndrome	2.46e-05	0.000269	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IRS1—polycystic ovary syndrome	2.44e-05	0.000268	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HMMR—polycystic ovary syndrome	2.43e-05	0.000266	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—LHB—polycystic ovary syndrome	2.4e-05	0.000263	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	2.38e-05	0.000261	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—HSD3B2—polycystic ovary syndrome	2.34e-05	0.000257	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	2.33e-05	0.000256	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—LHB—polycystic ovary syndrome	2.32e-05	0.000254	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HSD3B1—polycystic ovary syndrome	2.31e-05	0.000254	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	2.3e-05	0.000252	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—GAB1—polycystic ovary syndrome	2.3e-05	0.000252	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—ISYNA1—polycystic ovary syndrome	2.28e-05	0.00025	CbGpPWpGaD
Mitoxantrone—ABCG2—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	2.28e-05	0.00025	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKR1C1—polycystic ovary syndrome	2.27e-05	0.000249	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—HSD3B2—polycystic ovary syndrome	2.27e-05	0.000249	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—AKT2—polycystic ovary syndrome	2.26e-05	0.000248	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NAMPT—polycystic ovary syndrome	2.24e-05	0.000245	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKR1C1—polycystic ovary syndrome	2.2e-05	0.000241	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PNPLA2—polycystic ovary syndrome	2.16e-05	0.000237	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—LHB—polycystic ovary syndrome	2.11e-05	0.000231	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SULT2A1—polycystic ovary syndrome	2.09e-05	0.000229	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKR1C3—polycystic ovary syndrome	2.09e-05	0.000229	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—HSD3B2—polycystic ovary syndrome	2.06e-05	0.000226	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TNRC6B—polycystic ovary syndrome	2.05e-05	0.000225	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SRD5A1—polycystic ovary syndrome	2.05e-05	0.000225	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—RRM2—polycystic ovary syndrome	2.02e-05	0.000222	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SULT2A1—polycystic ovary syndrome	2.02e-05	0.000222	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—polycystic ovary syndrome	2.01e-05	0.000221	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKR1C1—polycystic ovary syndrome	2e-05	0.000219	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—BCL2—polycystic ovary syndrome	1.97e-05	0.000216	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—RRM2—polycystic ovary syndrome	1.96e-05	0.000215	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—STAR—polycystic ovary syndrome	1.95e-05	0.000214	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—YAP1—polycystic ovary syndrome	1.95e-05	0.000214	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKR1C2—polycystic ovary syndrome	1.94e-05	0.000213	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TEAD2—polycystic ovary syndrome	1.94e-05	0.000213	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—YAP1—polycystic ovary syndrome	1.89e-05	0.000207	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	1.88e-05	0.000206	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NAMPT—polycystic ovary syndrome	1.87e-05	0.000205	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.86e-05	0.000204	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	1.86e-05	0.000203	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP11A1—polycystic ovary syndrome	1.85e-05	0.000203	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SULT2A1—polycystic ovary syndrome	1.84e-05	0.000202	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.84e-05	0.000201	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NAMPT—polycystic ovary syndrome	1.81e-05	0.000199	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	1.8e-05	0.000198	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP11A1—polycystic ovary syndrome	1.79e-05	0.000196	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—RRM2—polycystic ovary syndrome	1.78e-05	0.000195	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	1.78e-05	0.000195	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—TCF7L2—polycystic ovary syndrome	1.76e-05	0.000193	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—polycystic ovary syndrome	1.76e-05	0.000193	CbGpPWpGaD
Mitoxantrone—BTK—Innate Immune System—IL6—polycystic ovary syndrome	1.75e-05	0.000192	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—AKR1C3—polycystic ovary syndrome	1.75e-05	0.000192	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HMMR—polycystic ovary syndrome	1.74e-05	0.000191	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	1.73e-05	0.00019	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SLC2A4—polycystic ovary syndrome	1.73e-05	0.00019	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP17A1—polycystic ovary syndrome	1.72e-05	0.000189	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—YAP1—polycystic ovary syndrome	1.72e-05	0.000188	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—AKR1C3—polycystic ovary syndrome	1.69e-05	0.000185	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP17A1—polycystic ovary syndrome	1.66e-05	0.000182	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HSD3B1—polycystic ovary syndrome	1.66e-05	0.000182	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	1.65e-05	0.000181	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—PRL—polycystic ovary syndrome	1.65e-05	0.000181	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NAMPT—polycystic ovary syndrome	1.65e-05	0.000181	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP11A1—polycystic ovary syndrome	1.63e-05	0.000179	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PNPLA2—polycystic ovary syndrome	1.63e-05	0.000178	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	1.61e-05	0.000176	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SRD5A1—polycystic ovary syndrome	1.54e-05	0.000169	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—AKR1C3—polycystic ovary syndrome	1.54e-05	0.000169	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—LHB—polycystic ovary syndrome	1.52e-05	0.000166	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP17A1—polycystic ovary syndrome	1.51e-05	0.000166	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	1.51e-05	0.000166	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	1.51e-05	0.000166	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—TH—polycystic ovary syndrome	1.49e-05	0.000163	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—HSD3B2—polycystic ovary syndrome	1.48e-05	0.000162	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—STAR—polycystic ovary syndrome	1.47e-05	0.000161	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	1.47e-05	0.000161	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—SLC2A4—polycystic ovary syndrome	1.45e-05	0.000159	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—TH—polycystic ovary syndrome	1.44e-05	0.000158	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKR1C1—polycystic ovary syndrome	1.43e-05	0.000157	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	1.41e-05	0.000154	CbGpPWpGaD
Mitoxantrone—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	1.4e-05	0.000154	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—SLC2A4—polycystic ovary syndrome	1.4e-05	0.000154	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NCOR1—polycystic ovary syndrome	1.38e-05	0.000152	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP19A1—polycystic ovary syndrome	1.36e-05	0.000149	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—NRG1—polycystic ovary syndrome	1.36e-05	0.000149	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SULT2A1—polycystic ovary syndrome	1.32e-05	0.000145	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP19A1—polycystic ovary syndrome	1.32e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—polycystic ovary syndrome	1.32e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HMMR—polycystic ovary syndrome	1.31e-05	0.000144	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—TH—polycystic ovary syndrome	1.31e-05	0.000144	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—RRM2—polycystic ovary syndrome	1.28e-05	0.00014	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—SLC2A4—polycystic ovary syndrome	1.27e-05	0.00014	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HSD3B1—polycystic ovary syndrome	1.25e-05	0.000137	CbGpPWpGaD
Mitoxantrone—ABCB1—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	1.23e-05	0.000135	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—YAP1—polycystic ovary syndrome	1.23e-05	0.000135	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—MTHFR—polycystic ovary syndrome	1.22e-05	0.000134	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—GNAS—polycystic ovary syndrome	1.22e-05	0.000133	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP19A1—polycystic ovary syndrome	1.2e-05	0.000131	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	1.2e-05	0.000131	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	1.2e-05	0.000131	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NAMPT—polycystic ovary syndrome	1.18e-05	0.00013	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—GNAS—polycystic ovary syndrome	1.18e-05	0.000129	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP11A1—polycystic ovary syndrome	1.17e-05	0.000128	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IRS2—polycystic ovary syndrome	1.16e-05	0.000127	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—NCOR1—polycystic ovary syndrome	1.16e-05	0.000127	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—LHB—polycystic ovary syndrome	1.14e-05	0.000125	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—NCOR1—polycystic ovary syndrome	1.12e-05	0.000123	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—HSD3B2—polycystic ovary syndrome	1.12e-05	0.000122	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—AKR1C3—polycystic ovary syndrome	1.1e-05	0.000121	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—CYP1A1—polycystic ovary syndrome	1.1e-05	0.00012	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP17A1—polycystic ovary syndrome	1.09e-05	0.000119	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKR1C1—polycystic ovary syndrome	1.08e-05	0.000118	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—GNAS—polycystic ovary syndrome	1.07e-05	0.000117	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—CYP1A1—polycystic ovary syndrome	1.06e-05	0.000116	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—MTHFR—polycystic ovary syndrome	1.02e-05	0.000112	CbGpPWpGaD
Mitoxantrone—BTK—Immune System—IL6—polycystic ovary syndrome	1.02e-05	0.000112	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—NCOR1—polycystic ovary syndrome	1.02e-05	0.000112	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IRS1—polycystic ovary syndrome	1.01e-05	0.000111	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	1e-05	0.00011	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SULT2A1—polycystic ovary syndrome	9.94e-06	0.000109	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—MTHFR—polycystic ovary syndrome	9.9e-06	0.000109	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—INS—polycystic ovary syndrome	9.72e-06	0.000107	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—CYP1A1—polycystic ovary syndrome	9.66e-06	0.000106	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—RRM2—polycystic ovary syndrome	9.63e-06	0.000106	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	9.51e-06	0.000104	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—TH—polycystic ovary syndrome	9.41e-06	0.000103	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—AKT2—polycystic ovary syndrome	9.39e-06	0.000103	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—YAP1—polycystic ovary syndrome	9.28e-06	0.000102	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—SLC2A4—polycystic ovary syndrome	9.15e-06	0.0001	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	9.07e-06	9.94e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—MTHFR—polycystic ovary syndrome	9.01e-06	9.87e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—SERPINE1—polycystic ovary syndrome	8.93e-06	9.79e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NAMPT—polycystic ovary syndrome	8.92e-06	9.78e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP11A1—polycystic ovary syndrome	8.81e-06	9.65e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP19A1—polycystic ovary syndrome	8.6e-06	9.43e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—AKR1C3—polycystic ovary syndrome	8.32e-06	9.12e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—PPARG—polycystic ovary syndrome	8.3e-06	9.1e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP17A1—polycystic ovary syndrome	8.19e-06	8.98e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—POMC—polycystic ovary syndrome	8.18e-06	8.97e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Metabolism—INS—polycystic ovary syndrome	8.14e-06	8.92e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	8.08e-06	8.86e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—PPARG—polycystic ovary syndrome	8.03e-06	8.8e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—POMC—polycystic ovary syndrome	7.92e-06	8.68e-05	CbGpPWpGaD
Mitoxantrone—CYP1B1—Metabolism—INS—polycystic ovary syndrome	7.87e-06	8.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.71e-06	8.45e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—GNAS—polycystic ovary syndrome	7.68e-06	8.42e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—NCOR1—polycystic ovary syndrome	7.32e-06	8.02e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—PPARG—polycystic ovary syndrome	7.3e-06	8.01e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—POMC—polycystic ovary syndrome	7.2e-06	7.9e-05	CbGpPWpGaD
Mitoxantrone—ABCG2—Metabolism—INS—polycystic ovary syndrome	7.16e-06	7.85e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—TH—polycystic ovary syndrome	7.08e-06	7.77e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	7.03e-06	7.71e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—CYP1A1—polycystic ovary syndrome	6.94e-06	7.6e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—SLC2A4—polycystic ovary syndrome	6.89e-06	7.55e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.87e-06	7.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.66e-06	7.3e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP19A1—polycystic ovary syndrome	6.48e-06	7.1e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—MTHFR—polycystic ovary syndrome	6.47e-06	7.09e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	6.13e-06	6.71e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.93e-06	6.5e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—GNAS—polycystic ovary syndrome	5.78e-06	6.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.72e-06	6.27e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—NCOR1—polycystic ovary syndrome	5.51e-06	6.04e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.49e-06	6.02e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	5.43e-06	5.95e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—PPARG—polycystic ovary syndrome	5.24e-06	5.75e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—CYP1A1—polycystic ovary syndrome	5.22e-06	5.73e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—POMC—polycystic ovary syndrome	5.17e-06	5.67e-05	CbGpPWpGaD
Mitoxantrone—CYP2E1—Metabolism—INS—polycystic ovary syndrome	5.14e-06	5.64e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	5.12e-06	5.62e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	5.04e-06	5.53e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—MTHFR—polycystic ovary syndrome	4.87e-06	5.34e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.36e-06	4.78e-05	CbGpPWpGaD
Mitoxantrone—ABCC1—Disease—IL6—polycystic ovary syndrome	4.25e-06	4.66e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	4.25e-06	4.65e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.99e-06	4.38e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—PPARG—polycystic ovary syndrome	3.95e-06	4.33e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—POMC—polycystic ovary syndrome	3.89e-06	4.27e-05	CbGpPWpGaD
Mitoxantrone—ABCB1—Metabolism—INS—polycystic ovary syndrome	3.87e-06	4.24e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.56e-06	3.91e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.39e-06	3.72e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	3.22e-06	3.53e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	3e-06	3.29e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.43e-06	2.67e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.4e-06	2.63e-05	CbGpPWpGaD
Mitoxantrone—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.39e-06	2.62e-05	CbGpPWpGaD
